Other than the well described regulatory role of IRF5 risk variants58, we also identified that genetic variants at TRIM27, TRIM26, RLP4, NEXN, LAP3, GBP5, RBM43 and SLNF5 genes could be implicated in SS through changes in gene expression. This evidence concerns the gene RBM43 and synovial sarcoma.